01/02/2021
DIAsource supplies multiple CE-IVD marked COVID-19 tests.
ELISA COVID-19 kits :
- CE, IVD marked
- detection of IgA, IgG and IgM antibodies against recombinant SARS-CoV-2 Nucleocapsid protein (NCP) or Receptor-binding domain (RBD)
- NP – immunodominant, highly antigenic epitope; important in early diagnosis
- RBD - S1 subunit of the spike protein, anti RBD antibodies are highly specific;IgA - indicator of the onset of the immune response
- Easy protocol for programming on any OPEN ELISA platform
- The kits are also available in SmartEIA format designed for automated processing and evaluation using the Agility® analyser
Rapid Screening Tests (RST) COVID-19 kits:
- CE, IVD marked
- Two versions :
- -RAPU08COVID19AG for the qualitative detection of SARS-CoV-2 antigens present in human nasopharynx.
- -RAPU08COVID19 for qualitative detection of IgG and IgM antibodies to 2019-nCoV in human whole blood, serum or plasma specimens.
- Results on the spot – 10 minutes
- High sensitivity and specificity
NEW :also available now MICRO-ARRAY COVID-19 kits
- CE, IVD marked
- combination of selected parts of the specific antigens of SARS-CoV-2 (NCP, RBD, Spike S2, E, ACE2, PLPro protein)
- and antigens for exclusion cross-reactivity with other endemic coronaviruses (MERS-CoV, SARS-CoV, HCoV 229E Np, HCoV NL63 Np).
For more information or to order : customer.service@diasource.be
To request a quote :eric.maes@diasource.be
back